REGistry of Long-term AnTithrombotic TherApy-1

RecruitingOBSERVATIONAL
Enrollment

2,000

Participants

Timeline

Start Date

January 15, 2015

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2026

Conditions
Coronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD))Peripheral Artery Disease
Interventions
DRUG

Antiplatelet Drug

single or dual antiplatelets, triple antithrombotic therapy

Trial Locations (1)

121552

RECRUITING

National Medical Research Center for Cardiology, Ministry of Health of Russian Federation, Moscow

All Listed Sponsors
lead

National Medical Research Center for Cardiology, Ministry of Health of Russian Federation

OTHER_GOV